{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:24:46Z","timestamp":1773289486465,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T00:00:00Z","timestamp":1250121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00213-009-1627-z","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T05:54:41Z","timestamp":1250056481000},"page":"491-499","source":"Crossref","is-referenced-by-count":61,"title":["Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients"],"prefix":"10.1007","volume":"206","author":[{"given":"Ana","family":"Alkelai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amihai","family":"Rigbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyra","family":"Kanyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,13]]},"reference":[{"issue":"6","key":"1627_CR1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajmg.b.30746","volume":"147B","author":"AF Hadithy Al","year":"2008","unstructured":"Al Hadithy AF, Wilffert B, Stewart RE, Looman NM, Bruggeman R, Brouwers JR, Matroos GE, van Os J, Hoek HW, van Harten PN (2008) Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African\u2013Caribbean inpatients: differences in association with dopamine and serotonin receptors. Am J Med Genet B Neuropsychiatr Genet 147B(6):890\u2013897","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"1627_CR2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","volume":"12","author":"MJ Arranz","year":"2007","unstructured":"Arranz MJ, de Leon J (2007) Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol Psychiatry 12(8):707\u2013747","journal-title":"Mol Psychiatry"},{"key":"1627_CR3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.1961.03040120016004","volume":"175","author":"F Ayd","year":"1961","unstructured":"Ayd F (1961) A survey of drug induced extrapyramidal reaction. JAMA 175:1054\u20131060","journal-title":"JAMA"},{"issue":"20","key":"1627_CR4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/11.20.2517","volume":"11","author":"VS Basile","year":"2002","unstructured":"Basile VS, Masellis M, Potkin SG, Kennedy JL (2002) Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum Mol Genet 11(20):2517\u20132530","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"1627_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.devbrainres.2003.09.017","volume":"146","author":"A Bithell","year":"2003","unstructured":"Bithell A, Alberta J, Hornby F, Stiles CD, Williams BP (2003) Expression of the guanine nucleotide exchange factor, mr-gef, is regulated during the differentiation of specific subsets of telencephalic neurons. Brain Res Dev Brain Res 146(1\u20132):107\u2013118","journal-title":"Brain Res Dev Brain Res"},{"key":"1627_CR6","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1017\/S0317167100003309","volume":"Suppl 1","author":"PJ Blanchet","year":"2003","unstructured":"Blanchet PJ (2003) Antipsychotic drug-induced movement disorders. Can J Neurol Sci Suppl 1:S101\u2013S107","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"1627_CR7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbi028","volume":"31","author":"I Bombin","year":"2005","unstructured":"Bombin I, Arango C, Buchanan RW (2005) Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull 31(4):962\u2013977","journal-title":"Schizophr Bull"},{"issue":"3","key":"1627_CR8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","volume":"16","author":"RJ Buckanovich","year":"1996","unstructured":"Buckanovich RJ, Yang YY, Darnell RB (1996) The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 16(3):1114\u20131122","journal-title":"J Neurosci"},{"issue":"4","key":"1627_CR9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/jnp.9.4.562","volume":"9","author":"MP Caligiuri","year":"1997","unstructured":"Caligiuri MP, Lohr JB (1997) Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients. J Neuropsychiatry Clin Neurosci 9(4):562\u2013567","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"1627_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1176\/jnp.12.1.34","volume":"12","author":"MP Caligiuri","year":"2000","unstructured":"Caligiuri MP, Peavy G (2000) An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 12(1):34\u201339","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"1627_CR11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.150.9.1343","volume":"150","author":"MP Caligiuri","year":"1993","unstructured":"Caligiuri MP, Lohr JB, Jeste DV (1993) Parkinsonism in neuroleptic\u2013naive schizophrenic patients. Am J Psychiatry 150(9):1343\u20131348","journal-title":"Am J Psychiatry"},{"issue":"supp","key":"1627_CR12","first-page":"25","volume":"65","author":"DE Casey","year":"2004","unstructured":"Casey DE (2004) Pathophysiology of antipsychotics drug-induced movement disorders. J Clin Psychiatry 65(supp):25\u201328","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1627_CR13","first-page":"81","volume":"28","author":"MH Chakos","year":"1992","unstructured":"Chakos MH, Mayerhoff DI, Loebel AD, Alvir JM, Lieberman JA (1992) Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull 28(1):81\u201386","journal-title":"Psychopharmacol Bull"},{"issue":"12","key":"1627_CR14","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1176\/ajp.152.12.1724","volume":"152","author":"A Chatterjee","year":"1995","unstructured":"Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA (1995) Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152(12):1724\u20131729","journal-title":"Am J Psychiatry"},{"key":"1627_CR15","unstructured":"Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, Sullivan PF, Psychiatric GWAS Consortium Coordinating Committee (2009)Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166(5):540\u2013556"},{"issue":"2","key":"1627_CR16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/79923","volume":"26","author":"GA Cox","year":"2000","unstructured":"Cox GA, Mahaffey CL, Nystuen A, Letts VA, Frankel WN (2000) The mouse fidgetin gene defines a new role for AAA family proteins in mammalian development. Nat Genet 26(2):198\u2013202","journal-title":"Nat Genet"},{"issue":"2","key":"1627_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/14622416.10.2.161","volume":"10","author":"JJ Crowley","year":"2009","unstructured":"Crowley JJ, Sullivan PF, McLeod HL (2009) Pharmacogenomic genome-wide association studies: lessons learned thus far. Pharmacogenomics 10(2):161\u2013163","journal-title":"Pharmacogenomics"},{"issue":"6","key":"1627_CR18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajmg.b.30544","volume":"144B","author":"V Dolzan","year":"2007","unstructured":"Dolzan V, Plesnicar BK, Serretti A, Mandelli L, Zalar B, Koprivsek J, Breskvar K (2007) Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment. Am J Med Genet B Neuropsychiatr Genet 144B(6):809\u2013815","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"1627_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0031-6997(25)06933-9","volume":"47","author":"M Ebadi","year":"1995","unstructured":"Ebadi M, Srinivasan SK (1995) Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders. Pharmacol Rev 47(4):575\u2013604","journal-title":"Pharmacol Rev"},{"issue":"10","key":"1627_CR20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ng1433","volume":"36","author":"N Freimer","year":"2004","unstructured":"Freimer N, Sabatti C (2004) The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 36(10):1045\u20131051","journal-title":"Nat Genet"},{"key":"1627_CR21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.115.7.577","volume":"115","author":"FA Freyhan","year":"1959","unstructured":"Freyhan FA (1959) Therapeutic implications of differential effects of new phenothiazine compounds. Am J Psychiatry 115:577\u2013585","journal-title":"Am J Psychiatry"},{"issue":"24","key":"1627_CR22","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1242\/dev.00840","volume":"130","author":"M Garcia-Dominguez","year":"2003","unstructured":"Garcia-Dominguez M, Poquet C, Garel S, Charnay P (2003) Ebf gene function is required for coupling neuronal differentiation and cell cycle exit. Development 130(24):6013\u20136025","journal-title":"Development"},{"issue":"7273","key":"1627_CR23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","volume":"321","author":"J Geddes","year":"2000","unstructured":"Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321(7273):1371\u20131376","journal-title":"BMJ"},{"issue":"7","key":"1627_CR24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/FPC.0b013e32800ffbb4","volume":"17","author":"L Greenbaum","year":"2007","unstructured":"Greenbaum L, Strous RD, Kanyas K, Merbl Y, Horowitz A, Karni O, Katz E, Kotler M, Olender T, Deshpande SN, Lancet D, Ben-Asher E, Lerer B (2007) Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenet Genomics 17(7):519\u2013528","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"1627_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/tpj.2008.6","volume":"9","author":"L Greenbaum","year":"2009","unstructured":"Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, Korner M, Lancet D, Ben-Asher E, Lerer B (2009) Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3\u2032-untranslated region. Pharmacogenomics J 9(2):103\u2013110","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"1627_CR26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00228-007-0450-x","volume":"64","author":"A Gunes","year":"2008","unstructured":"Gunes A, Dahl ML, Spina E, Scordo MG (2008) Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients. Eur J Clin Pharmacol 64(5):477\u2013482","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1627_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00228-006-0234-8","volume":"63","author":"C G\u00fczey","year":"2007","unstructured":"G\u00fczey C, Scordo MG, Spina E, Landsem VM, Spigset O (2007) Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. Eur J Clin Pharmacol 63(3):233\u2013241","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"1627_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hup.918","volume":"23","author":"PM Haddad","year":"2008","unstructured":"Haddad PM, Dursun SM (2008) Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol 23(Suppl 1):15\u201326","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"1627_CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/schbul\/23.4.567","volume":"23","author":"TE Hansen","year":"1997","unstructured":"Hansen TE, Casey DE, Hoffman WF (1997) Neuroleptic intolerance. Schizophr Bull 23(4):567\u2013582","journal-title":"Schizophr Bull"},{"issue":"Suppl 3","key":"1627_CR30","first-page":"iii22","volume":"253","author":"G Hirose","year":"2006","unstructured":"Hirose G (2006) Drug induced parkinsonism: a review. J Neurol 253(Suppl 3):iii22\u2013iii24","journal-title":"J Neurol"},{"issue":"1","key":"1627_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","volume":"161","author":"S Janno","year":"2004","unstructured":"Janno S, Holi M, Tuisku K, Wahlbeck K (2004) Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients. Am J Psychiatry 161(1):160\u2013163","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1627_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-5-5","volume":"5","author":"S Janno","year":"2005","unstructured":"Janno S, Holi MM, Tuisku K, Wahlbeck K (2005) Validity of Simpson\u2013Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol 5(1):5","journal-title":"BMC Neurol"},{"issue":"7","key":"1627_CR33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.mp.4001054","volume":"7","author":"R Kaiser","year":"2002","unstructured":"Kaiser R, Tremblay PB, Klufm\u00f6ller F, Roots I, Brockm\u00f6ller J (2002) Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Mol Psychiatry 7(7):695\u2013705","journal-title":"Mol Psychiatry"},{"issue":"10","key":"1627_CR34","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1371\/journal.pgen.0020171","volume":"2","author":"P Khaitovich","year":"2006","unstructured":"Khaitovich P, Kelso J, Franz H, Visagie J, Giger T, Joerchel S, Petzold E, Green RE, Lachmann M, P\u00e4\u00e4bo S (2006) Functionality of intergenic transcription: an evolutionary comparison. PLoS Genet 2(10):e171","journal-title":"PLoS Genet"},{"issue":"3","key":"1627_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","volume":"8","author":"A Kindmark","year":"2008","unstructured":"Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, Carlsson S, Cederbrant KE, Gibson NJ, Armstrong M, Lagerstr\u00f6m-Ferm\u00e9r ME, Dells\u00e9n A, Brown EM, Thornton M, Dukes C, Jenkins SC, Firth MA, Harrod GO, Pinel TH, Billing-Clason SM, Cardon LR, March RE (2008) Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 8(3):186\u2013195","journal-title":"Pharmacogenomics J"},{"key":"1627_CR36","doi-asserted-by":"crossref","unstructured":"Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. (2008) Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull. [Epub ahead of print]","DOI":"10.1093\/schbul\/sbn146"},{"issue":"6","key":"1627_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.mp.4001983","volume":"12","author":"T Lencz","year":"2007","unstructured":"Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, Malhotra AK (2007) Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12(6):572\u2013580","journal-title":"Mol Psychiatry"},{"issue":"R1","key":"1627_CR38","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1):R48\u2013R59","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1627_CR39","first-page":"20","volume":"44","author":"V Lerner","year":"2007","unstructured":"Lerner V, Libov I, Kaptsan A, Miodownik C, Dwolatzky T, Levine J (2007) The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel. Isr J Psychiatry Relat Sci 44(1):20\u201328","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"12","key":"1627_CR40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209\u20131223","journal-title":"N Engl J Med"},{"issue":"8","key":"1627_CR41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4088\/JCP.v65n0809","volume":"65","author":"JP Lindenmayer","year":"2004","unstructured":"Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M (2004) Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. J Clin Psychiatry 65(8):1084\u20131089","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"1627_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R (2008) SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study. N Engl J Med 359(8):789\u2013799","journal-title":"N Engl J Med"},{"key":"1627_CR43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mp.2009.3","volume":"14","author":"YZ Liu","year":"2009","unstructured":"Liu YZ, Pei YF, Guo YF, Wang L, Liu XG, Yan H, Xiong DH, Zhang YP, Levy S, Li J, Haddock CK, Papasian CJ, Xu Q, Ma JZ, Payne TJ, Recker RR, Li MD, Deng HW (2009) Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol Psychiatry. 14:668\u2013680","journal-title":"Mol Psychiatry."},{"issue":"10","key":"1627_CR44","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/jnr.21666","volume":"86","author":"MK Lobo","year":"2008","unstructured":"Lobo MK, Yeh C, Yang XW (2008) Pivotal role of early B-cell factor 1 in development of striatonigral medium spiny neurons in the matrix compartment. J Neurosci Res 86(10):2134\u20132146","journal-title":"J Neurosci Res"},{"issue":"22","key":"1627_CR45","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1101\/gad.1367605","volume":"19","author":"JA Martens","year":"2005","unstructured":"Martens JA, Wu PY, Winston F (2005) Regulation of an intergenic transcript controls adjacent gene transcription in Saccharomyces cerevisiae. Genes Dev 19(22):2695\u20132704","journal-title":"Genes Dev"},{"issue":"2","key":"1627_CR46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.168.2.221","volume":"168","author":"RG McCreadie","year":"1996","unstructured":"McCreadie RG, Thara R, Kamath S, Padmavathy R, Latha S, Mathrubootham N, Menon MS (1996) Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry 168(2):221\u2013226","journal-title":"Br J Psychiatry"},{"key":"1627_CR47","first-page":"1127","volume":"182","author":"C Medinar","year":"1962","unstructured":"Medinar C, Kramer MD, Kurland AA (1962) Biperiden in the treatment of phenothiazine-induced extrapyramidal reactions. JAMA 182:1127\u20131128","journal-title":"JAMA"},{"issue":"1","key":"1627_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10(1):79\u2013104","journal-title":"Mol Psychiatry"},{"issue":"1\u20133","key":"1627_CR49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2007.10.018","volume":"100","author":"J Modestin","year":"2008","unstructured":"Modestin J, Wehrli MV, Stephan PL, Agarwalla P (2008) Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr Res 100(1\u20133):97\u2013107","journal-title":"Schizophr Res"},{"issue":"4","key":"1627_CR50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5414\/CPP43163","volume":"43","author":"Y Nakazono","year":"2005","unstructured":"Nakazono Y, Abe H, Murakami H, Koyabu N, Isaka Y, Nemoto Y, Murata S, Tsutsumi Y, Ohtani H, Sawada Y (2005) Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients. Int J Clin Pharmacol Ther 43(4):163\u2013171","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1627_CR51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1192\/bjp.187.2.137","volume":"187","author":"S Park","year":"2005","unstructured":"Park S, Ross-Degnan D, Adams AS, Sabin J, Kanavos P, Soumerai SB (2005) Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study. Br J Psychiatry 187:137\u2013142","journal-title":"Br J Psychiatry"},{"issue":"8","key":"1627_CR52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904\u2013909","journal-title":"Nat Genet"},{"issue":"3","key":"1627_CR53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559\u2013575","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1627_CR54","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ng0508-491","volume":"40","author":"D Reich","year":"2008","unstructured":"Reich D, Price AL, Patterson N (2008) Principal component analysis of genetic data. Nat Genet 40(5):646\u2013649","journal-title":"Nat Genet"},{"issue":"16","key":"1627_CR55","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/archinte.165.16.1882","volume":"165","author":"PA Rochon","year":"2005","unstructured":"Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH (2005) Atypical antipsychotics and parkinsonism. Arch Intern Med 165(16):1882\u20131888","journal-title":"Arch Intern Med"},{"issue":"9","key":"1627_CR56","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0813112106","volume":"106","author":"M Ruggiu","year":"2009","unstructured":"Ruggiu M, Herbst R, Kim N, Jevsek M, Fak JJ, Mann MA, Fischbach G, Burden SJ, Darnell RB (2009) Rescuing Z+agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci USA 106(9):3513\u20133518","journal-title":"Proc Natl Acad Sci USA"},{"key":"1627_CR57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"G Simpson","year":"1970","unstructured":"Simpson G, Angus MP (1970) Scale for assessment extrapyramidal side effects. Acta Psychiatr Scand 212:11\u201319","journal-title":"Acta Psychiatr Scand"},{"issue":"8411","key":"1627_CR58","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(84)91516-2","volume":"2","author":"PJ Stephen","year":"1984","unstructured":"Stephen PJ, Williamson J (1984) Drug-induced parkinsonism in the elderly. Lancet 2(8411):1082\u20131083","journal-title":"Lancet"},{"issue":"1","key":"1627_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","volume":"29","author":"TS Stroup","year":"2003","unstructured":"Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA (2003) The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29(1):15\u201331","journal-title":"Schizophr Bull"},{"issue":"6","key":"1627_CR60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mp.2008.25","volume":"13","author":"PF Sullivan","year":"2008","unstructured":"Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, Liu W, Downing AM, Lieberman J, Close SL (2008) Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13(6):570\u2013584","journal-title":"Mol Psychiatry"},{"issue":"8","key":"1627_CR61","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1176\/ajp.2006.163.8.1438","volume":"163","author":"DE Tenback","year":"2006","unstructured":"Tenback DE, van Harten PN, Slooff CJ, van Os J (2006) Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Am J Psychiatry 163(8):1438\u20131440","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1627_CR62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbn126","volume":"35","author":"PF Whitty","year":"2009","unstructured":"Whitty PF, Owoeye O, Waddington JL (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35(2):415\u2013424","journal-title":"Schizophr Bull"},{"issue":"31","key":"1627_CR63","doi-asserted-by":"crossref","first-page":"22352","DOI":"10.1074\/jbc.M603626200","volume":"281","author":"Y Yang","year":"2006","unstructured":"Yang Y, Mahaffey CL, B\u00e9rub\u00e9 N, Frankel WN (2006) Interaction between fidgetin and protein kinase A-anchoring protein AKAP95 is critical for palatogenesis in the mouse. J Biol Chem 281(31):22352\u201322359","journal-title":"J Biol Chem"},{"issue":"16","key":"1627_CR64","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1523\/JNEUROSCI.5569-08.2009","volume":"29","author":"M Yin","year":"2009","unstructured":"Yin M, Liu S, Yin Y, Li S, Li Z, Wu X, Zhang B, Ang SL, Ding Y, Zhou J (2009) Ventral mesencephalon-enriched genes that regulate the development of dopaminergic neurons in vivo. J Neurosci 29(16):5170\u20135182","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1627-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1627-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:34:59Z","timestamp":1739298899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1627-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,13]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1627-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,13]]}}}